E-LIB Suche - Ergebnisse für: Walraven, I.

1

P2.26-02 Patient-Reported Symptom Monitoring Improves 1-Yea..:

Walraven, I. ; Billingy, N. ; Tromp, V....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S400 , 2023

Link: https://doi.org/10.1016/..

2

Patients characteristics and general practitioners' managem..:

Chaabouni, A. ; Houwen, J. ; Walraven, I....
Journal of Psychosomatic Research. 169 (2023) - p. 111249 , 2023

Link: https://doi.org/10.1016/..

3

Selecting a PRO-CTCAE-based subset for patient-reported sym..:

Feldman, E. ; Pos, F.J. ; Smeenk, R.J....
ESMO Open. 8 (2023) 1 - p. 100775 , 2023

Link: https://doi.org/10.1016/..

4

OC-0104 A novel approach to assess preoperative toxicity in..:

van Amelsfoort, R. ; González, P. ; Simões, R....
Radiotherapy and Oncology. 182 (2023) - p. S65-S66 , 2023

Link: https://doi.org/10.1016/..

5

Chronic fatigue in childhood cancer survivors is associated..:

Penson, A. ; Walraven, I. ; Bronkhorst, E....
ESMO Open. 8 (2023) 6 - p. 102044 , 2023

Link: https://doi.org/10.1016/..

6

Adjuvant chemotherapy is superior to chemoradiation after D..:

de Steur, W.O. ; van Amelsfoort, R.M. ; Hartgrink, H.H....
Annals of Oncology. 32 (2021) 3 - p. 360-367 , 2021

Link: https://doi.org/10.1016/..

7

OC-0519 Registration and image quality of T2w 3D TSE scans ..:

Van Pelt, V. ; Janssen, T. ; Walraven, I....
Radiotherapy and Oncology. 133 (2019) - p. S271 , 2019

Link: https://doi.org/10.1016/..

8

PO-0928 Treatment plan quality assessment for focal dose es..:

Van Schie, M. ; Janssen, T. ; Eekhout, D....
Radiotherapy and Oncology. 133 (2019) - p. S498 , 2019

Link: https://doi.org/10.1016/..

9

OC-0064 Reducing radiotherapy dose to involved lymph nodes ..:

Van Diessen, J. ; Kwint, M. ; Sonke, J....
Radiotherapy and Oncology. 133 (2019) - p. S27-S28 , 2019

Link: https://doi.org/10.1016/..

10

PV-0625: Quality of Life trajectories and correlation with ..:

De Vries, K. ; Walraven, I. ; Incrocci, L..
Radiotherapy and Oncology. 127 (2018) - p. S331 , 2018

Link: https://doi.org/10.1016/..

11

EP-1383: The use of Real World Evidence to audit NTCP-model..:

Kwint, M.H. ; Walraven, I. ; Marshall, M.S....
Radiotherapy and Oncology. 127 (2018) - p. S755-S756 , 2018

Link: https://doi.org/10.1016/..

12

Treatment Variation of Sequential versus Concurrent Chemora..:

Walraven, I. ; Damhuis, R.A. ; ten Berge, M.G....
Clinical Oncology. 29 (2017) 11 - p. e177-e185 , 2017

Link: https://doi.org/10.1016/..

13

Effectiveness of insulin therapy in people with Type 2 diab..:

Mast, M. R. ; Walraven, I. ; Hoekstra, T....
Diabetic Medicine. 33 (2016) 6 - p. 794-802 , 2016

Link: https://doi.org/10.1111/..

14

3003 Facility case volume and survival in patients with sta..:

Damhuis, R. ; Walraven, I. ; Widder, J...
European Journal of Cancer. 51 (2015) - p. S596 , 2015

Link: https://doi.org/10.1016/..

15

Fasting proinsulin levels are significantly associated with..:

Walraven, I. ; van 't Riet, E. ; Stehouwer, C. D. A....
Diabetologia. 56 (2013) 5 - p. 1148-1154 , 2013

Link: https://doi.org/10.1007/..